A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate

NCT01110317 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: paliperidone palmitate 100 mg

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.